628996291

1702 CHAUVEAU ot al

BLOOD. 1 SEPTEMBER 2005 • VOLUME 106. NUMBER5

32.    Verhasselt V. Vanden Berghe W. '/anderheyda N. Willems F. Haegeman G. Goldman M. N-acetyl-L-cysteine inhibits primary human T celi responses al Ihe dendrłtic celi level: associalion with NF-kappaB inhibilion. J Immunol. 1999:162:2569-2574.

33.    Shcrtman K. Liu YJ. Mouse and human dendritic ceflsubtypes. NatRev Immunol. 20Ce:2:151-161.

34.    Kim HP. Wang X. Galbiati F. RylerSW. Choi AM. Caveolae comparlmentalizalion ofhemeoxygen-ase-1 in endothelial cells. FaSEB J. 2004:18: 1080-1089.

35.    Huang XL. Ling YL. Ling YQ. Zhou JL. Liu Y.

Wang QH. Heme oxygenase-l in cholecystoki-nin-octapeptipe altenuated injury ol pulmonary artery smooth muscle cells induced by Ipcpdy-saccharide and its signal Iransductbn mecha-nism. World J Gastroenterol. 2004:10:1789-1794.

36.    Tsukiji T. Takahashi T. Mizcbuchi S. el al. Gene expression of heme oxygenase-l during glial acti-valion by lipcpolysaccharide. Res Commun Mol Pathol Pharmacol. 2000:107:187-193.

37.    Camhi SL. Alam J. Wiegand GW. Chin BY. Chcl AM. Transcriptional actbaticn of the HO-1 gen© by lipopolysaccharide is mediated by 5' distal en-hancers: roi© of reactive oxygen interrrediates and AP-1. Am J RespirCell Mol Biol. 1998:18: 226-234.

38.    Kadowaki N. Ho S. Antonenko S. et al. Subsels of human dendritic celi precursors express different Tdl-like receplors and respond to different micro-bel anligens. J Exp Med. 2001:194:863-869.

39.    Piemonti L. Monti P. Allavena P. et al. Glucoccrti-ccfds afl8d human dendritic celi differenlialion and maluraticn. J Immunol. 1959:162:6473-6481.

40.    Steinbrink K. Wolfl M. Jonulei! H. Knop J. Enk AH.

Induction of tolerance by IL-10-treated dendritic cells. J Immunol. 1997:159:4772 4780.

41.    Demidem A. Taylor J R. Grammer SF. S treilel n JW. Comparison of eflecls of trartsforming growlh factor-beta and cyclosporin a on antigen-present-ing cells of dood and epidermis. J lnvest Dermatol. 1991:96:401-407.

42.    Penna G. Adorini L. 1 Alpha.25-dihydroxyvitamin D3 inhibits differentiation. maturation.activation. and survival of dendritic cells leading to impaired alloreactbeT celi acth/ation. J Immunol. 2000: 164:2405-2411.

43.    Banch8reau J. Paczesny S. Blanco P. el al. Dendritic cells: conlrollers of the immune system and a new promlse forimmunotherapy. Ann N YAcad Sc i. 2003:9*37:189187.

44.    Van Parijs L. Perez VL. Biuckians A. Maki RG. London Ca. Abbas AK. Role of interleukin 12 and coslimulatcrs in T celi anergy in vivo. J Exp Med. 1997:186:1119-1128.

45.    Banchereau J. Steinman RM. Dendritic cells and thecontrol of immunity. Naturę. 1996:392:245-252.

46.    Lenschow DJ. Walunas TL. Bluestone JA.

CD28' B7 system of T celi costimulalion. Annu Rev Immunol. 1996:14:233-258.

47.    lezzi G. Karjalainen K. Lanzavecchia A. The dura-ticn of antigenic stimubticn determines the fate of nah/eandeffectorT cells. Immunity. 1956:8:89-95.

48.    Groux H. Bigler M. de Vries JE. Rcncarolo MG. lnterleukin-1 o induces a bng-term antigen-spe-cific anergic State in human ĆD4 cells. J Exp Med. 1996:184:1929.

49.    Akdis CA. Blesken T. Akdis M. Wuthrich B. Blaser K. Role of interleukin 10 in specitic immuno-therapy. JClin Irwest. 1968:102:98-106.

50.    Levings MK. Gregori S. Tresoldi E. Cazzaniga S. BoniniC. Ronoarolo MG. Differenliatbn of Tri cells by immalure dendritic cells reguires IL-10 but not CD25 CD4 Treg cells. Blood. 2005:105: 1162-1169.

51.    Song R. Mahidhara RS. Zhcu Z. et al. Carbon monoxide inhitils T lymphocyte prdiferation via caspase-dependent pathway. J Immund. 2004: 172:1220-1226.

52.    DeVry CG. Valdez M. Ga o L. el al. RDP58. a novel immunomodulatorypeptide. ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyeli-tis. J Neuroimmunol. 2004:152:33-43.

53.    Woo J. tyer S. Cornejo MC. et al. Slress protein-induced immunosippression: inhibition ofcellular immune effector functions foliowi ng overexpes-sion of haem oxygenase (HSP 32). Transpl Immunol. 1558:6:84-93.

54.    Woo J. tyer S. Mori N. Buelow R. Allevetion of graft-versus-hc<s! disease after conditioning with ccbalt-protcpcrphyrin. an inducer of heme oxy-genase-1. Transplantatbn. 2000:65:623-633.

55.    Malsue H. Edelbaum D. Shalhevet D. el al. Gen-eration and function of reactbe oxygen species in dendritic cells during antigen presentation. J Immunol. 2003:171:3010-3018.

56.    Fbss Kd. Tcnegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natł Acad Sci USA. 1997:94:10925-10930.

57.    Kav/ashima A. Oda Y. Yachie A. Koizumi S. Na-kanishi I. Heme oxygenase-1 deficiency: thefirst autopsycase. Hum Pathol. 2002:33:125-130.

58.    Yachie A. Niida Y. Wada T. el al. Oxidative stress causes enhanced endolhelial celi injury in human heme oxygenase-l deficiency'. J Clin lnvest. 1999:103:129-135.